GE HealthCare Technologies Product — Total revenues decreased by 14.4% to $3.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $3.12B to $3.35B. Over 4 years (FY 2021 to FY 2025), Product — Total revenues shows an upward trend with a 5.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong product demand and market penetration, while a decrease suggests slowing sales or competitive pressure.
Represents the total gross inflow of economic benefits arising from the sale of physical medical equipment and hardware...
Standard revenue line item reported by all medical technology peers.
gehc_segment_product_total_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.79B | $2.79B | $2.79B | $2.79B | $2.90B | $3.01B | $3.34B | $3.13B | $3.21B | $3.19B | $3.60B | $3.05B | $3.21B | $3.20B | $3.62B | $3.12B | $3.26B | $3.38B | $3.91B | $3.35B |
| QoQ Change | — | +0.0% | +0.0% | -0.2% | +4.2% | +3.8% | +11.0% | -6.3% | +2.6% | -0.8% | +12.9% | -15.3% | +5.3% | -0.2% | +13.2% | -13.9% | +4.7% | +3.4% | +15.7% | -14.4% |
| YoY Change | — | — | — | — | +4.0% | +7.9% | +19.7% | +12.3% | +10.7% | +5.8% | +7.6% | -2.7% | -0.2% | +0.5% | +0.7% | +2.4% | +1.7% | +5.4% | +7.8% | +7.3% |